≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Carcinoma in situ, bladder

DOID MESH PheWeb

CD2_INSITU_BLADDER

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D09.0&
Hospital discharge: ICD-9 2337
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D09.0&
Cause of death: ICD-9 2337
Cause of death: ICD-8 $!$

66

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

66

diagram downward connector

Check minimum number of events None

66

diagram downward connector

Include endpoints None

66

diagram downward connector
CD2_INSITU_BLADDER

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D09
Name in latin Carcinoma in situ vesicae urinariae

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 66 11 55
Unadjusted prevalence (%) 0.02 0.01 0.03
Mean age at first event (years) 69.44 61.67 71.00

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_BLADDER – Carcinoma in situ, bladder
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ, bladder
after Carcinoma in situ, bladder

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carcinoma in situ, bladder

↥